Chronic News and Research

RSS

Majority of consumers lack awareness on new health insurance options under the Affordable Care Act

In a series of nationwide focus groups conducted by Intuit TurboTax®, a majority of consumers who participated lacked awareness of their new health insurance options under the Affordable Care Act, sometimes referred to as "Obamacare". In addition, a most of them did not know if they would qualify for financial assistance to help cover the cost of health insurance.

29 Mar 2013

New evidence shows older adults with dementia can be taken off antipsychotic medications

Most older adults with dementia can successfully be taken off antipsychotic medications, which have negative side effects and increase the risk of death, finds a new evidence review from The Cochrane Library.

29 Mar 2013

Study: Heart failure medications highly cost effective in saving lives

A UCLA study shows that heart failure medications recommended by national guidelines are highly cost effective in saving lives and may also provide savings to the health care system.

29 Mar 2013

State roundup: Calif. report card shows improved care for kids

The latest developments in health policy from California, the District of Columbia, Georgia, Maryland, Minnesota, Oregon and Texas.

29 Mar 2013

Study: New genetic variants may increase cancer risk

The European Collaborative Oncological Gen-Environmental Study (COGS) project, whose main goal is to decipher the complex genetic bases of breast, prostate and ovarian cancers, publishes today a total of 12 research articles in several prestigious journals, including Nature Genetics, Nature Communications, The American Journal of Human Genetics and PLOS Genetics.

28 Mar 2013

Inflammation and epigenetics: an interview with Dr Belkina and Dr Denis, Boston University School of Medicine

Inflammation can be thought of as taking two major forms: acute or chronic. Acute inflammation, which can be painful, usually arises quickly and resolves quickly. It accompanies bacterial infections, traumatic injury and is useful to fight infections and promote healing.

28 Mar 2013

First Edition: March 28, 2013

Today's headlines include various stories about the health law's implementation at both the federal and state level.

28 Mar 2013

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.

28 Mar 2013

Research findings could lead to improved treatment for neuropathic pain

An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, says a key protein in Schwann cells performs a critical, perhaps overarching, role in regulating the recovery of peripheral nerves after injury.

28 Mar 2013

Environmental enrichment increases endogenous cell migration, facilitates functional repair

A team of Korean researchers investigated whether "environmental enrichment" can improve the neurobehavioral function of six week-old mice after transplantation of adipose-derived stem cells to treat hypoxic-ischemic brain injury, and found that brain repair (neurogenesis) was aided in some animals through exercise-induced fibroblast growth factor 2 (FGF2), a strong pro-angiogenic factor.

28 Mar 2013

IDIBELL signs agreement with Histocell to use patent for acute pulmonary diseases with stem cells

The Bellvitge Biomedical Research Institute has signed a licensing agreement with the Spanish biotech company Histocell to make use of a patent for the treatment of acute pulmonary diseases with mesenchymal stem cells.

28 Mar 2013

Tecfidera gets FDA approval for adults with relapsing forms of MS

The U.S. Food and Drug Administration today approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis.

28 Mar 2013

Lightlake to present Phase II clinical trial results of opioid antagonist nasal spray at APA Annual Meeting

Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing addiction treatments, announced today that a scientific abstract based on results of the Company's Phase II clinical trial of its opioid antagonist nasal spray treatment for patients with Binge Eating Disorder has been accepted for presentation at the American Psychiatric Association Annual Meeting taking place in San Francisco, California, May 18-22, 2013.

27 Mar 2013

Academic performance linked to risky health behaviors in children and teens

Academic performance is linked to risky health behaviors in children and teens, reports a new review in the Journal of Adolescent Health. Health risks that can impact academic success include behaviors tracked by the Centers for Disease Control (CDC) in young people, such as unhealthy diets, physical inactivity, violence, inappropriate sexual behaviors, and alcohol, drug or tobacco use.

27 Mar 2013

Novel molecular mechanism can prevent aging and cancer progression, say researchers

University of Montreal researchers have discovered a novel molecular mechanism that can potentially slows the aging process and may prevent the progression of some cancers.

27 Mar 2013

Researchers develop tablet-based testing system to identify signs of potential concussion

From Junior Seau, former San Diego Chargers linebacker, to Dave Duerson, former Chicago Bears safety - who both committed suicide as a result of chronic traumatic encephalopathy, traumatic brain injuries have been making gruesome headlines at an alarming rate.

27 Mar 2013

Depression also diminish health benefits of physical activities, say researchers

Depression may inhibit the anti-inflammatory effects typically associated with physical activity and light-to-moderate alcohol consumption, according to researchers at Duke Medicine.

27 Mar 2013

Study examines diabetes risk factors in young people transitioning to adult care

Type 1 diabetes is a condition in which the body does not produce insulin and cannot convert sugar, starches and other food into energy. Generally diagnosed during childhood or adolescence, the disease requires lifelong access to medical care and intensive daily self-management.

26 Mar 2013

Researchers identify monoclonal antibody that directly kills lymphocytic leukemia cells

Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.

26 Mar 2013

Novel cell therapy effective in treating aggressive form of childhood leukemia

Two children with an aggressive form of childhood leukemia had a complete remission of their disease—showing no evidence of cancer cells in their bodies—after treatment with a novel cell therapy that reprogrammed their immune cells to rapidly multiply and destroy leukemia cells.

26 Mar 2013

Chronic News and Research

Majority of consumers lack awareness on new health insurance options under the Affordable Care Act

New evidence shows older adults with dementia can be taken off antipsychotic medications

Study: Heart failure medications highly cost effective in saving lives

State roundup: Calif. report card shows improved care for kids

Study: New genetic variants may increase cancer risk

Inflammation and epigenetics: an interview with Dr Belkina and Dr Denis, Boston University School of Medicine

First Edition: March 28, 2013

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

Research findings could lead to improved treatment for neuropathic pain

Environmental enrichment increases endogenous cell migration, facilitates functional repair

IDIBELL signs agreement with Histocell to use patent for acute pulmonary diseases with stem cells

Tecfidera gets FDA approval for adults with relapsing forms of MS

Lightlake to present Phase II clinical trial results of opioid antagonist nasal spray at APA Annual Meeting

Academic performance linked to risky health behaviors in children and teens

Novel molecular mechanism can prevent aging and cancer progression, say researchers

Researchers develop tablet-based testing system to identify signs of potential concussion

Depression also diminish health benefits of physical activities, say researchers

Study examines diabetes risk factors in young people transitioning to adult care

Researchers identify monoclonal antibody that directly kills lymphocytic leukemia cells

Novel cell therapy effective in treating aggressive form of childhood leukemia

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News